국가: 뉴질랜드
언어: 영어
출처: Ministry for Primary Industries
tilmicosin
AgriHealth NZ Limited
tilmicosin
tilmicosin 300 g/litre
Antibiotic
ACVM Registered
2015-08-24
AgriHealth NZ Ltd TilmoVet Version: FINAL VIAL LABEL Packaging Text Date: 27 JULY 2023 [AGRIHEALTH LOGO] RESTRICTED VETERINARY MEDICINE KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY CRITICALLY IMPORTANT ANTIBIOTIC TILMOVET 300 Injection Contains tilmicosin 300 mg/mL Net Contents 25mL / 50mL / 100mL / 250mL READ LABEL AND LEAFLET BEFORE USE INDICATIONS For use in cattle for the treatment of bovine respiratory disease (BRD) associated with _Mannheimia (Pasteurella) _ _haemolytica_ and _Pasteurella multocida_, and other organisms sensitive to tilmicosin. For the treatment of footrot in sheep associated with _D. _ _nodosus _and_ F. necrophorum_. DIRECTIONS FOR USE INJECT ONLY SUBCUTANEOUSLY in the anterior half of the neck. CATTLE: For BRD, administer a single subcutaneous dose of 10 mg/kg of body weight (1mL per 30kg). Do not inject more than 15mL per injection site. SHEEP: For footrot, administer a single subcutaneous dose of 5mg/kg of body weight (1mL per 60kg). Do not treat lambs weighing less than 15kg. If no improvement is noted within 48 hours, the diagnosis should be re-evaluated. CAUTION: The safety of tilmicosin has not been established in pregnant cattle or in animals used for breeding purposes. Intramuscular injection will cause a local reaction that may result in trim loss. CONTRAINDICATION: Intravenous injection in cattle may be fatal. Injection has been shown to be fatal in swine, non-human primates, goats and lambs less than 15 kg bodyweight and it may be fatal in horses. IT IS AN OFFENCE FOR USERS OF THIS PRODUCT TO CAUSE RESIDUES EXCEEDING THE RELEVANT MRL IN THE FOOD NOTICE: MAXIMUM RESIDUE LEVELS FOR AGRICULTURAL COMPOUNDS WITHHOLDING PERIOD MEAT: Animals producing meat and offal for human consumption must not be slaughtered within Cattle: 28 days of last treatment Sheep: 42 days of last treatment MILK: 35 days Store below 25°C protected from sunlight. Store locked up. Use within 28 days of opening. Manufactured in Europe by Huvepharma EOOD Registered in New Zealand to AgriHealth NZ Ltd 전체 문서 읽기